519 672 2121
Close mobile menu
Showing 191 - 200 of 548

Avandia

A Canada-wide settlement was reached and approved on June 13, 2019 by the Supreme Court of Nova Scotia. The Claims Deadline for filing a claim under the settlement was on July 15, 2020. The settlement has now concluded and no further claims are being accepted. Avandia, a drug used to treat diabetes, is associated with...

Continue reading the post titled Avandia

Actos

Actos (pioglitazone hydrochloride) is an oral anti-diabetic drug manufactured by Takeda and prescribed to decrease blood sugar levels in patients with type 2 diabetes. A Canada-wide settlement has been reached in five proposed class actions relating to the prescription drugs ACTOS®, APO-Pioglitazone and SANDOZ-Pioglitazone. Hearings were held in the supervising Courts in Québec and Ontario...

Continue reading the post titled Actos

Yasmin/Yaz

In August 19, 2010, a motion to authorize the bringing of a class action and to ascribe the status of representatives was commenced by Siskinds, Desmeules, the Quebec firm affiliated to Siskinds LLP, against the defendant Bayer Inc. (the “defendant”), on behalf of all persons in Québec, including their successors, assigns, family members and any...

Continue reading the post titled Yasmin/Yaz

Diet Drugs

Settlement Notice: The deadline for applying to receive settlement benefits has passed and all settlement funds have been distributed. There are 2 separate Class Actions underway involving the diet drugs Fenfluramine Dexfenfluramine. Fenfluramine was sold under the trade names of Ponderal and Pondimin. Dexfenfluramine was sold under the trade name of Redux. We are class...

Continue reading the post titled Diet Drugs